Notice of Change to Extend the Application Due Date, Expiration Date, Anticipated Number of Awards and Award Project Period for RFA-FD-14-016 "Evaluation of In Vitro Release Methods for Liposomal Drug Products (U01)"

Notice Number: NOT-FD-14-010

Key Dates
Release Date: May 20, 2014

Related Announcements
RFA-FD-14-016

Issued by
Food and Drug Administration (FDA)

Purpose

This Notice of Change is to inform potential applicants of changes to the published RFA-FD-14-016 "Evaluation of in Vitro Release Methods for Liposomal Drug Products (U01)" as indicated below:

Key Dates are changed as follows: The Application Due Date is extended to June 15, 2014, by 5:00 PM local time of applicant organization. Expiration Date has changed to June 16, 2014.

Section II. Award Information is changed as follows:

Funds Available and Anticipated Number of Awards:  The FDA and partner components intend to commit $500,000 per award. Awards are contingent upon the availability of funds. Future year amounts will depend on annual appropriations and performance.

Award Project Period:  The scope of the proposed project should determine the project period.  The maximum project period is 2 year.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Nan Zheng
Food and Drug Administration (FDA)
Telephone: 240-402-7972
Email: Nan.Zheng@fda.hhs.gov

 

NIH Office of Extramural Research Logo
Department of Health and Human Services (HHS) - Home Page
Department of Health
and Human Services (HHS)
USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.